CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,674 | +642.4% | 147 | +818.8% | 0.00% | – |
| Q2 2023 | $899 | -70.0% | 16 | -60.0% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 40 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 40 | +33.3% | 0.00% | – |
| Q1 2022 | $2,000 | -90.9% | 30 | -89.8% | 0.00% | -100.0% |
| Q4 2021 | $22,000 | -42.1% | 294 | -13.5% | 0.00% | -66.7% |
| Q3 2021 | $38,000 | +442.9% | 340 | +639.1% | 0.00% | +200.0% |
| Q2 2021 | $7,000 | +16.7% | 46 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -25.0% | 46 | -11.5% | 0.00% | -100.0% |
| Q4 2020 | $8,000 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |